Business Context and Reporting Period
This Form 8-K Current Report was filed by TopSpin Medical, Inc. on March 7, 2011. The registrant is a Delaware corporation headquartered in Kfar Shmaryahu, Israel, operating in the medical technology sector.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
On March 7, 2011, the Board of Directors elected two new directors:
- Eitan Shtarkman: Elected as a director and serving as Chief Executive Officer. He joined the Company in February 2011 after working as an entrepreneur in dental medicine and previously serving as CEO of Chmir-Nir.
- Ascher Shmulewitz: Elected as a director. He is the Company's controlling shareholder, owning 88.98% of the outstanding voting securities. He leads Medgenesis Partners Ltd., an investment firm focused on medical and wellness technologies.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, specific risk factors, or contingencies. The document contains no management commentary regarding future business strategy beyond the biographical details of the new directors.
Investor Verification Checklist
- Verify the exact ownership percentage of Ascher Shmulewitz (stated as 88.98%) and any related party transaction implications.
- Confirm the effective date of Eitan Shtarkman's appointment as CEO and any associated compensatory arrangements not detailed in this summary.
- Review the Company's most recent 10-K or 10-Q filings for financial data, as this 8-K contains no financial metrics.